Skip to main content
Dr. Aravind Asokan

The collaboration between Aravind Asokan, researcher at the Gene Therapy Center, and Charles Gersbach, a Duke biomedical engineer, to develop gene therapy for Duchenne Muscular Dystrophy – a rapidly worsening form of muscular dystrophy – is spotlighted on UNC’s website March 6.

Dr. Asokan’s expertise is in gene delivery. Dr. Gersbach’s background is in genome editing. Together they hope to modify DNA sequences to correct disease-causing mutations.

Read the full article on UNC-Duke research collaborations